Radiometer Proudly Sponsors 2023 World Sepsis Congress

Congress attendees can hear from more than 85 interdisciplinary speakers who will discuss Sepsis from various perspectives. Topics will include the role of technology like AI, machine learning, big data; the link to pandemics and AMR; the latest research; policy impacts; and trial designs. This year’s focus is to show the interdependencies between Sepsis, pandemics and antimicrobial resistance.

The two-day Congress will include discussions on the impact of global health threats and tactics for addressing them, industry-driven research and highlights of regional initiatives aimed at addressing Sepsis care. The diverse range of this year’s speakers includes thought leaders, medical professionals, impacted patients and families and policy makers.

Since 2015, Radiometer is a proud supporter of the Global Sepsis Alliance, a non-profit organization of more than 100 organizations with the mission to provide global leadership, increase awareness, and reduce the worldwide burden of Sepsis. This year, Radiometer will sponsor the World Sepsis Congress, which covers 16 distinctive and highly relevant sessions:

Day 1

Session 1: Key Success Factors to Address Global Health Threats

Session 2: The Health Economic and Human Burden of Infections and Pandemics

Session 3: Overcoming Silos to Address Infection-Related Global Health Threats

Session 4: The Quality of Healthcare Systems and QI Efforts on Outcomes from Sepsis and Pandemics

Session 5: Advances and Challenges by Our Regional Sepsis Alliances

Session 6: Advances in Timely Pathogen and Sepsis Detection

Day 2

Session 7: The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level

Session 8: The Potential and Challenges to Intervene with the Immune Response

Session 9: Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR

Session 10: Lessons from the Pandemic to Fight Common Infections and Sepsis

Session 11: Understanding and Improving Long-Term Outcomes After Sepsis and Covid-19

Session 12: Neonatal Sepsis Platforms and Guidelines

Session 13: The Impact of Survivors and Family Members to Improve Sepsis Awareness and Advocacy

Session 14: Maternal Sepsis: Why is it Still in the Top 3 for Global Incidence of Sepsis?

Session 15: Harnessing the Media to Advance the Global Fight Against Sepsis

Session 16: An Update on Research on Sepsis

Do you have colleagues who would be interested in attending? Please share the news and courage others to join. You can sign up and find more information here.

About Radiometer

Whatever comes next, we make sure life comes first.

Radiometer develops, manufactures, and markets solutions for blood sampling, blood gas analysis, transcutaneous monitoring, immunoassay testing, and related IT management systems. Today, Radiometer products and solutions are used in hospitals, clinics, and laboratories in over 130 countries, providing information on critical parameters in acute care diagnostics.

Through connected solutions, expert knowledge, and trusted partnership, we help health care professionals make diagnostic decisions to improve patient care.